Left L3/4, L4/5, and L5/S1 Facet Rhizotomy with Radiofrequency Ablation of Left L2, L3, L4 Medial Branch, L5 Dorsal Primary Rami, and S1 Facet Branch
DATE: April 13, 2011
Patient: XXXXXXXX
DOB: XXXXXXXX
Physician: XXXXXXXX, M.D.
HISTORY: He relates persistent
severe back pain. Examination negative
for radiculopathy, sciatica, or myelopathy.
The
following interventional procedure was carried out at Pain Clinic fluoroscopy
suite after discussing risks, benefits, alternatives and complications to
procedure.
PROCEDURE: Left L3/4, L4/5, and L5/S1
facet rhizotomy with radiofrequency ablation of left L2, L3, L4 medial branch,
L5 dorsal primary rami, and S1 facet branch.
PRE &
POST PROCEDURE DIAGNOSIS: Lumbosacral spondylosis/low back pain/lumbar facet syndrome.
Relevant
pre-procedure assessment carried out.
Integument corresponding to area examined negative for any active
infection. Vitals’ monitored and patient confirmed stable prior to proceeding
with procedure.
Patient
positioned prone on fluoroscopy table, AP and ipsilateral oblique views of
lumbosacral spine carried out and skin marked for above nerves. Area prepped with Betadine and draped
sterile. Local anesthesia obtained with
30-gauge one-inch needle and 2% buffered Xylocaine with epi. Subsequently, 10 cm radiofrequency cannula
with 10 mm active tip inserted, 22-gauge.
Needle localized to lie at the angle of superior articular process and
transverse process with distal bony resistance.
Impedance reading between 200 and 400 confirmed at all sites prior to
carrying out sensory and motor testing.
Positive sensory testing at less than 1 to 2 mV confirmed at all sites
with positive motor testing for localized muscle taping and absence of distal
symptoms in extremity. Needle tip for L5
and S1 localized at superior articular process, sacral ala angle, and
superolateral corner of S1 foramen.
Subsequently,
local anesthesia obtained with 0.5 ml to 1 ml of 0.5% Marcaine and
radiofrequency ablation done at setting of 60 seconds at 80° repeated twice at
each site with slight needle repositioning.
Negative complications monitored at all sites. Needles withdrawn after instillation of 10 mg
of Kenalog post-ablation.
Patient
tolerated procedure well. No
complications encountered, no blood loss assessed. Stable clinical condition confirmed post
procedure. Safety with
ambulation/mobility assessed prior to discharge. Post-procedure care and discharge
instructions reviewed and a written copy given to patient.
Note: Additional
history intake, interval history updates, procedure specific informed consent,
pre and post-procedure assessment, post-procedure care and discharge
instructions documented in patient’s chart, please refer to.
Patient to be
scheduled for similar intervention the opposite side in two weeks’ time.
Sincerely,
___________________________
XXXXXXXX,
M.D.
No comments:
Post a Comment